New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
Exploring the role of omega-3s, vitamin D, and personalized diets in managing aromatase inhibitor side effects for breast cancer patients. Emerging research shows targeted dietary strategies can signi...
A 12-week clinical trial explores time-restricted eating’s potential to improve mitochondrial function and autophagy in early-stage Huntington’s disease patients. Groundbreaking research i...
New research reveals konjac glucomannan’s unique ability to combat obesity through mechanical and biochemical mechanisms, with frozen gel form showing 18% greater efficacy in mice studies. Cutti...
Emerging research shows personalized dietary interventions can significantly reduce side effects and improve adherence to breast cancer endocrine therapy. New AI-driven nutrition strategies and microb...
Exploring how diet and supplements can alleviate aromatase inhibitor-induced arthralgia and improve quality of life for breast cancer patients. Emerging research reveals how targeted nutritional inter...
New research highlights konjac glucomannan’s potential in weight management and metabolic health through gut microbiota modulation and SCFA production. Recent studies demonstrate konjac glucoman...
A 12-week TRE protocol (6h window) is being tested for early Huntington’s Disease, showing potential benefits for mitochondrial function and autophagy with 80% adherence expected. New clinical t...
Recent studies highlight dietary interventions like omega-3 fatty acids and vitamin D for managing aromatase inhibitor-induced arthralgia in ER+ breast cancer patients. New research supports dietary i...
New research reveals how modified forms of konjac glucomannan differentially impact glucose and lipid metabolism in obesity through gut microbiota alterations. Cutting-edge studies demonstrate konjac ...
